Marilyn O. Robbie

544 total citations
18 papers, 430 citations indexed

About

Marilyn O. Robbie is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marilyn O. Robbie has authored 18 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Microbiology, 10 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Marilyn O. Robbie's work include Reproductive tract infections research (11 papers), Urinary Tract Infections Management (9 papers) and Reproductive Health and Contraception (3 papers). Marilyn O. Robbie is often cited by papers focused on Reproductive tract infections research (11 papers), Urinary Tract Infections Management (9 papers) and Reproductive Health and Contraception (3 papers). Marilyn O. Robbie collaborates with scholars based in United States, Australia and Austria. Marilyn O. Robbie's co-authors include Richard L. Sweet, Julius Schachter, Marilyn Ohm-Smith, Daniel V. Landers, W K Hadley, Keith Hadley, Joseph L. Mills, Deborah Draper, Moses Grossman and William R. Crombleholme and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and American Journal of Obstetrics and Gynecology.

In The Last Decade

Marilyn O. Robbie

17 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn O. Robbie United States 10 253 200 111 86 84 18 430
W R Bowie Canada 14 261 1.0× 252 1.3× 39 0.4× 56 0.7× 80 1.0× 23 576
Višnja Škerk Croatia 11 132 0.5× 226 1.1× 52 0.5× 31 0.4× 60 0.7× 38 415
Marilyn J. Ohm United States 8 147 0.6× 190 0.9× 59 0.5× 102 1.2× 119 1.4× 11 397
Linda Pead United Kingdom 13 94 0.4× 321 1.6× 86 0.8× 31 0.4× 79 0.9× 23 522
Paolo Lanzafame Italy 12 308 1.2× 423 2.1× 155 1.4× 34 0.4× 94 1.1× 20 672
S Schönwald Croatia 12 131 0.5× 337 1.7× 35 0.3× 29 0.3× 40 0.5× 25 507
Angela Whiley United Kingdom 8 141 0.6× 163 0.8× 33 0.3× 68 0.8× 33 0.4× 11 413
Paola Nardini Italy 13 211 0.8× 155 0.8× 34 0.3× 33 0.4× 80 1.0× 26 460
C A Reichart United States 12 266 1.1× 144 0.7× 21 0.2× 55 0.6× 17 0.2× 14 459
M C Thirumoorthi United States 12 190 0.8× 287 1.4× 12 0.1× 133 1.5× 95 1.1× 23 519

Countries citing papers authored by Marilyn O. Robbie

Since Specialization
Citations

This map shows the geographic impact of Marilyn O. Robbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn O. Robbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn O. Robbie more than expected).

Fields of papers citing papers by Marilyn O. Robbie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn O. Robbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn O. Robbie. The network helps show where Marilyn O. Robbie may publish in the future.

Co-authorship network of co-authors of Marilyn O. Robbie

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn O. Robbie. A scholar is included among the top collaborators of Marilyn O. Robbie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn O. Robbie. Marilyn O. Robbie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hill, Prue, Marilyn O. Robbie, David G. Goodman, & Heinz Regele. (2003). Delayed renal allograft failure due to polyoma-virus-associated tubulointerstitial nephritis. Pathology. 35(2). 172–175. 1 indexed citations
2.
Robbie, Marilyn O. & Richard L. Sweet. (1993). Pelvic Inflammatory Disease: Risk Factors and Microbial Etiologies. Journal of Obstetric, Gynecologic & Neonatal Nursing. 22(2). 169–179. 4 indexed citations
3.
Walker, Cheryl K., D V Landers, Marilyn Ohm-Smith, et al.. (1991). Comparison of Cefotetan Plus Doxycycline With Cefoxitin Plus Doxycycline in the Inpatient Treatment of Acute Salpingitis. Sexually Transmitted Diseases. 18(2). 119–123. 9 indexed citations
4.
Crombleholme, William R., et al.. (1989). Prophylaxis in Caesarean section with cefmetazole and cefoxitin. Journal of Antimicrobial Chemotherapy. 23(suppl D). 97–104. 6 indexed citations
5.
Sweet, Richard L., Julius Schachter, Daniel V. Landers, Marilyn Ohm-Smith, & Marilyn O. Robbie. (1988). Treatment of hospitalized patients with acute pelvic inflammatory disease: Comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. American Journal of Obstetrics and Gynecology. 158(3). 736–741. 42 indexed citations
6.
Crombleholme, William R., et al.. (1987). Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections. American Journal of Obstetrics and Gynecology. 156(2). 507–512. 36 indexed citations
7.
Schachter, Julius, et al.. (1986). Experience with the Routine Use of Erythromycin for Chlamydial Infections in Pregnancy. New England Journal of Medicine. 314(5). 276–279. 69 indexed citations
8.
Crombleholme, William R., et al.. (1986). Sulbactam/Ampicillin versus Metronidazole/Gentamicin in the Treatment of Severe Pelvic Infections. Drugs. 31(Supplement 2). 11–13. 21 indexed citations
9.
Schachter, Julius, et al.. (1986). Experience with the Routine Use of Erythromycin for Chlamydial Infections in Pregnancy. Obstetrical & Gynecological Survey. 41(9). 564–564. 4 indexed citations
10.
Sweet, Richard L., et al.. (1985). In vitro adherence of Lactobacillus species to vaginal epithelial cells. American Journal of Obstetrics and Gynecology. 153(7). 740–743. 35 indexed citations
11.
Sweet, Richard L., Marilyn Ohm-Smith, Daniel V. Landers, & Marilyn O. Robbie. (1985). Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections. American Journal of Obstetrics and Gynecology. 152(7). 808–817. 11 indexed citations
12.
Robbie, Marilyn O. & Richard L. Sweet. (1983). Metronidazole use in obstetrics and gynecology: A review. American Journal of Obstetrics and Gynecology. 145(7). 865–881. 39 indexed citations
13.
Sweet, Richard L., Marilyn O. Robbie, Marilyn Ohm-Smith, & W K Hadley. (1983). Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. American Journal of Obstetrics and Gynecology. 145(3). 342–349. 34 indexed citations
14.
Sweet, Richard L., J Schachter, & Marilyn O. Robbie. (1982). Acute salpingitis: Role of Chlamydia in the United States. 2. 175–178. 9 indexed citations
15.
Mack, Harold C., et al.. (1982). Human artificial insemination: donors in Melbourne. From our medical schools.. PubMed. 11(3). 218, 20–4. 1 indexed citations
16.
Sweet, Richard L., Marilyn O. Robbie, & Keith Hadley. (1979). Cefoxitin in Treatment of Obstetric and Gynecologic Infections. Clinical Infectious Diseases. 1(1). 202–204. 5 indexed citations
17.
Sweet, Richard L., Joseph L. Mills, Keith Hadley, et al.. (1979). Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. American Journal of Obstetrics and Gynecology. 134(1). 68–74. 101 indexed citations
18.
Sweet, Richard L., Keith Hadley, Joseph L. Mills, & Marilyn O. Robbie. (1978). Experience with intravenous cefoxitin sodium in obstetrics and gynaecology. Journal of Antimicrobial Chemotherapy. 4(suppl B). 249–250. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W R Bowie Breakdown of academic impact, for papers by Višnja Škerk Breakdown of academic impact, for papers by Marilyn J. Ohm Breakdown of academic impact, for papers by Linda Pead Breakdown of academic impact, for papers by Paolo Lanzafame Breakdown of academic impact, for papers by S Schönwald Breakdown of academic impact, for papers by Angela Whiley Breakdown of academic impact, for papers by Paola Nardini Breakdown of academic impact, for papers by C A Reichart Breakdown of academic impact, for papers by M C Thirumoorthi
Rankless by CCL
2026